





- Stock: In Stock
- Model: 182114
0% Customers recommend this product
-
5 Awesome0%
-
4 Great0%
-
3 Average0%
-
2 Bad0%
-
1 Poor0%
Reviews Over Ramiton And kaps. firm 5mg/10mg No. 30
- (0)
Total Reviews (0)
click here write review to add review for this product.
Report this review.
Description
Ramiton And is the combined medicine, APF inhibitor. Ramipril and amlodipin for treatment of arterial hypertension at adult patients, arterial blood pressure which is properly controlled ramiprily and amlodipiny which appoint at the same time in the same dose, as in a combination.
Structure
-
1 capsule contains 5 mg of a ramipril and 10 mg of an amlodipin (that corresponds to 13.868 mg of the besilat of an amlodipin);
-
capsule excipients on 5 mg / 10 mg: microcrystalline cellulose; calcium hydrophosphate anhydrous; starch corn prezhelatinizirovanny; starch corn prezhelatinizirovanny low humidity; sodium krakhmalglikolit (type A); the sodium stearylfumarating; ferrous oxide red (E 172); titan dioxide (E 171); gelatin.
Contraindication
Hypersensitivity to a ramipril, an amlodipin, derivatives of dihydropyridines, APF inhibitors (angiotensin-converting enzyme) or to any excipient.
Arterial hypotension or hemodynamic unstable states.
ІІ and ІІІ pregnancy trimester.
Route of administration
Recommended initial daily dose – 1 capsule.
should accept Medicine daily 1 time a day at the same time, irrespective of food.
should not chew or crush the capsule.
Fixed combination is not suitablefor initial therapy of hypertensia.
In case of need, a medicament dose it is possible to change or to individually titrate components of a free combination.
Daily dose can be raised to maximum – 10 mg / 10 mg (1 capsule on 10 mg / 10 mg of 1 times a day).
recommends to apply
Feature of use
medicine with care at the patients who are at the same time accepting diuretics as loss of volume and/or amount of salt is possible. It is necessary to control function of kidneys and content of potassium in blood serum.Pregnant
is not recommended to use APF inhibitors during the first trimester of pregnancy. Use of APF inhibitors is contraindicated during II and III trimester of pregnancy.
Children
Medicine is not recommended to be applied to children due to the lack of data on safety and efficiency of its use in this age category of patients.
Drivers
After reception of the first dose or at increase in a dose is not recommended to run motor transport and to work with other mechanisms within several hours. It is recommended to be careful, especially at the beginning of therapy.
Overdose
Ramipril.
Symptoms caused by overdose of APF inhibitors can include an excessive peripheral vazodilatation (with the profound arterial hypotension, shock), bradycardia, an electrolytic imbalance, a renal failure. The condition of the patient should be controlled carefully.
Amlodipin.
Data on cases of deliberate overdose of the person are limited to.
Symptoms. On the basis of the available data assume that the heavy overdose can lead to an excessive peripheral vazodilatation and, perhaps, to reflex tachycardia, the profound and long system arterial hypotension, including cardiogenic shock with a lethal outcome.
Side effects
from organs of sight: a disorder of vision, including illegibility of sight, conjunctivitis.
from organs of hearing and a vestibular mechanism: a hearing disorder, a ring in ears.
from the respiratory system, bodies of a thorax and mediastinum: the unproductive irritating cough, bronchitis, sinusitis, short wind, a bronchospasm, including exacerbation of asthma, congestion of a nose, lung cancer.
from digestive tract: inflammation in a digestive tract, digestive disturbances, gastrointestinal discomfort, dyspepsia, diarrhea, nausea, vomiting; infrequently pancreatitis (isolated cases with a lethal outcome at use of APF inhibitors).
Storage conditionsto Store
in original packing at a temperature not above 25 °C. To store out of children's reach.
Specifications
Characteristics | |
Active ingredients | Amlodipin, Ramipril |
Amount of active ingredient | 5 mg + 10 mg |
Applicant | Darnitsa |
Code of automatic telephone exchange | C09BB07 Ramipril and amlodipin |
Interaction with food | It doesn't matter |
Light sensitivity | Not sensitive |
Market status | The branded generic |
Origin | Chemical |
Prescription status | According to the prescription |
Primary packing | blister |
Producer | ADAMED PHARM S.A. |
Quantity in packing | 30 capsules |
Release form | capsules for internal use |
Route of administration | Oral |
Sign | Import |
Storage temperature | from 5 °C to 25 °C |
Trade name | Ramiton |